Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitte M Knudsen

Showing results (281-290 of 332) with videos related to

Pageof 34
Sort By:
Frontiers in Pharmacology|May 20, 2020
Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial ProtocolOlga B Baltzersen, Herbert Y Meltzer, Vibe G Frokjaer, et al.
Biological Psychiatry|August 24, 2024
Effect of Antidepressant Treatment on 5-HT<sub>4</sub> Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive DisorderVibeke H Dam, Kristin Köhler-Forsberg, Brice Ozenne, et al.
Neuroscience Applied|July 14, 2025
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspectsDrummond E-Wen McCulloch, Matthias E Liechti, Kim Pc Kuypers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
In vivo quantification of cerebral translocator protein binding in humans using 6-chloro-2-(4'-123I-iodophenyl)-3-(N,N-diethyl)-imidazo[1,2-a]pyridine-3-acetamide SPECTLing Feng, Claus Svarer, Gerda Thomsen, et al.
Molecules (Basel, Switzerland)|April 5, 2020
In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [<sup>125</sup>I]Iodo-ASEM and [<sup>18</sup>F]ASEM as Radiotracers of Homo- and Heteromeric α7 Nicotinic Acetylcholine ReceptorsCornelius K Donat, Henrik H Hansen, Hanne D Hansen, et al.
Neuroscience Applied|July 14, 2025
The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsyMaja R Marstrand-Joergensen, Vibeke H Dam, Kirsten Vinter, et al.
Translational Psychiatry|July 12, 2022
Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 studyKristin Köhler-Forsberg, Brice Ozenne, Søren V Larsen, et al.
Bipolar Disorders|May 2, 2024
Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: A prospective fMRI studyHanne Lie Kjærstad, Luisa de Siqueira Rotenberg, Julian Macoveanu, et al.
ACS Omega|August 29, 2019
Synthesis and Pharmacological Evaluation of [<sup>11</sup>C]4-Methoxy-<i>N</i>-[2-(thiophen-2-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]benzamide as a Brain Penetrant PET Ligand Selective for the δ-Subunit-Containing γ-Aminobutyric Acid Type A ReceptorsElina T L'Estrade, Hanne D Hansen, Christina Falk-Petersen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2025
Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disordersKamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Pageof 34

Showing results (281-290 of 332) with videos related to

Sort By:
Pageof 34
Frontiers in Pharmacology|May 20, 2020
Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial ProtocolOlga B Baltzersen, Herbert Y Meltzer, Vibe G Frokjaer, et al.
Biological Psychiatry|August 24, 2024
Effect of Antidepressant Treatment on 5-HT<sub>4</sub> Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive DisorderVibeke H Dam, Kristin Köhler-Forsberg, Brice Ozenne, et al.
Neuroscience Applied|July 14, 2025
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspectsDrummond E-Wen McCulloch, Matthias E Liechti, Kim Pc Kuypers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
In vivo quantification of cerebral translocator protein binding in humans using 6-chloro-2-(4'-123I-iodophenyl)-3-(N,N-diethyl)-imidazo[1,2-a]pyridine-3-acetamide SPECTLing Feng, Claus Svarer, Gerda Thomsen, et al.
Molecules (Basel, Switzerland)|April 5, 2020
In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [<sup>125</sup>I]Iodo-ASEM and [<sup>18</sup>F]ASEM as Radiotracers of Homo- and Heteromeric α7 Nicotinic Acetylcholine ReceptorsCornelius K Donat, Henrik H Hansen, Hanne D Hansen, et al.
Neuroscience Applied|July 14, 2025
The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsyMaja R Marstrand-Joergensen, Vibeke H Dam, Kirsten Vinter, et al.
Translational Psychiatry|July 12, 2022
Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 studyKristin Köhler-Forsberg, Brice Ozenne, Søren V Larsen, et al.
Bipolar Disorders|May 2, 2024
Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: A prospective fMRI studyHanne Lie Kjærstad, Luisa de Siqueira Rotenberg, Julian Macoveanu, et al.
ACS Omega|August 29, 2019
Synthesis and Pharmacological Evaluation of [<sup>11</sup>C]4-Methoxy-<i>N</i>-[2-(thiophen-2-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]benzamide as a Brain Penetrant PET Ligand Selective for the δ-Subunit-Containing γ-Aminobutyric Acid Type A ReceptorsElina T L'Estrade, Hanne D Hansen, Christina Falk-Petersen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2025
Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disordersKamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Pageof 34